Compare Amphastar Pharmaceuticals Inc (AMPH) vs Etsy Inc (ETSY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Etsy Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while Etsy Inc trades at $80.74 (market cap $7.69B). The key difference: Etsy Inc is far larger — about 9.3× Amphastar Pharmaceuticals Inc's market cap, and Etsy Inc is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | ETSY | |
|---|---|---|
Market Cap | $826.08M | $7.69B |
Sector | Health | Consumer Cyclical |
52-Week High | $30.81 | $81.05 |
52-Week Low | $16.87 | $44.05 |
Enterprise Value | $1.22B | $9.34B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
ETSY trades at $81.05, up 4.28% recently, with a bullish technical outlook supported by positive moving averages and recent earnings beats. The company shows strong gross margins of 71.55% and positive cash flow trends, though net income declined to $162.98M in 2025. Analyst sentiment is mixed with 49% buy ratings but a consensus price target of $70.79 below current levels, highlighting valuation concerns amid competitive pressures.
Outlook remains cautious due to high P/E of 31.05 and negative shareholder equity, offset by operational improvements and AI-driven seller tools. Key risks include active buyer declines and heavy debt load, but sustained GMS growth and cost management could support recovery if execution strengthens.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →
